Award Data

The broader impact/commercial potential of this project is the rapid, cost-effective detection of natural gas leakage to improve public safety, mitigate global climate change, and decrease product loss. Natural gas is the largest provider of power in the United States. However, more than 80 Tg of leakage occurs at well pads and pipelines during production alone. Such leakage poses a public health ...

The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase 1 project includes: accelerating the pace of healthcare improvement by making information on high-need/high-cost patients instantly accessible and individually tailored to health care providers; transforming health intervention databases into active and dynamic learning communities about caring for high ...

The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project will be to develop engineered bacteria with the ability to oxidize the copper mineral chalcopyrite and gold. The majority of copper reserves are in chalcopyrite, which currently requires smelting. The US copper mining industry, due to regulatory restrictions, has a limited smelting capacity forcing US ...

This Small Business Technology Transfer Phase I project advances a cost-effective and scalable direct recycling method for producing battery-grade cathode materials from end-of-life (EOL) lithium-ion batteries. The commercialization of the proposed direct lithium-ion battery recycling technology will lower the energy consumption and emissions associated with battery production, reduce demand for r ...

The broader impact/commercial potential of this STTR project stems from the costs to U.S. food producers of outbreaks of animal diseases. Producers of poultry, pork, and other food proteins lose more than $1B each year to infectious diseases, including some that are transmitted through the air. For diseases having an airborne transmission route, protective technologies that are available are few a ...

The broader impact / commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to enable electrification of remote oil & gas processes to reduce methane emissions, improve on-site safety, and provide leak-detection and monitoring capabilities. This will be achieved by developing a robust, efficient, small-scale power generator capable of converting on-site fuel to e ...

Physically UnclonableFunctions (PUFs) have been proposed as central building blocks in cryptographic protocols and security architectures. PUFs are physical devices that exhibit a challenge/responsebehavior: when presented with a challenge, the device produces a response that is a random function of both the challenge and the physical properties of the device.In contrast to most digital designs, i ...

There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terriblemorbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditionalvaccines have proven to be a huge contribution to public health, they do have some limitations especially in the cont ...

Marburg virus (MARV) is a filamentous enveloped non-segmented negative sense RNA virus. This viruse is considered to be extremelydangerous with case fatality rates as high as 88-90%. Extensive efforts have gone towards effective vaccines for MARV prevention, however,none have been successfully established as licensed vaccines. Glycoprotein (GP) is the only surface protein of MARV. There are substa ...

Flow Pharma, Inc. is a biotechnology company in the San Francisco Bay Area developing fully synthetic cytotoxic T lymphocyte (CTL)stimulating peptide vaccines for Marburg virus. The FlowVax vaccine platform allows us to create dry powder formulations of biodegradablemicrospheres and TLR adjuvants incorporating class I and class II T cell epitopes. FlowVax vaccines can be designed for delivery by i ...